Xylem Inc. has reported a second-quarter 2025 revenue of $2.3 billion, marking a 6% increase on both a reported and organic basis. The company's earnings per share (EPS) saw a significant uptick, with a 16% increase to $0.93 on a reported basis and $1.26 on an adjusted basis.
Net income attributable to Xylem for the quarter was $226 million, translating to an EPS of $0.93. Adjusted net income, which excludes certain impacts, stood at $307 million, resulting in an EPS of $1.26. The net income margin also saw growth, increasing by 90 basis points to 9.8%.
Xylem's adjusted earnings before interest, tax, depreciation, and amortization (EBITDA) margin for the second quarter was 21.8%, reflecting a year-over-year increase of 100 basis points. This growth was attributed to productivity savings and strong price realization, which outpaced the impact of inflation and mix.
Looking ahead, Xylem has revised its full-year 2025 revenue guidance to approximately $8.9 to $9.0 billion, representing a 4 to 5% increase on a reported basis and a 4% increase on an organic basis. The company also raised its adjusted EBITDA margin expectations to approximately 21.3 to 21.8%, up 70 to 120 basis points from its 2024 results. This adjustment results in a revised full-year adjusted EPS guidance of $4.70 to $4.85.
Xylem's performance in the second quarter demonstrates robust organic revenue growth across all segments, setting the stage for a promising outlook for the remainder of 2025.
For more detailed information and reconciliations for certain non-GAAP items, interested parties can refer to Xylem’s second-quarter 2025 earnings materials posted on its investor relations website. As a result of these announcements, the company's shares have moved -1.03% on the market, and are now trading at a price of $130.60. Check out the company's full 8-K submission here.
